Skip to main content
Timothy Olson, MD, Pediatric Hematology & Oncology, Philadelphia, PA

Timothy Olson MD Ph.D.


Assistant Professor of Pediatrics Children's Hospital of Philadelphia University of Pennsylvania

Join to View Full Profile
  • 3401 Civic Center Blvd# ChildrenPhiladelphia, PA 19104

  • Phone+1 215-590-3535

  • Fax+1 215-590-3992

Dr. Olson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2008 - 2012
  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaResidency, Pediatrics, 2006 - 2008
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 2006

Certifications & Licensure

  • DE State Medical License
    DE State Medical License Current
  • PA State Medical License
    PA State Medical License 2006 - 2026
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Germline Duplication of ATG2B and GSKIP Genes Is Not Required for the Familial Myeloid Malignancy Syndrome Associated with the Duplication of Chromosome 14q32  
    David B Lieberman, Daria V Babushok, Timothy S Olson, Stella T Chou, Elizabeth O Hexner, Nature

Abstracts/Posters

  • Inducible SBDS Deficiency Impairs Bone Marrow Niche Function to Engraft Donor Hematopoietic Stem Cell after Transplantation
    Timothy S. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Inherited Hematopoietic Malignancies 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

  • Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow USA - English USA - Français USA - Nederlands Japan - Japanese Korea - 한국어 APAC - English USA - Deutsch
    Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow USA - English USA - Français USA - Nederlands Japan - Japanese Korea - 한국어 APAC - English USA - DeutschDecember 3rd, 2024
  • Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow
    Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone MarrowDecember 3rd, 2024
  • Turn Bio Commences Bone Marrow Rejuvenation Study
    Turn Bio Commences Bone Marrow Rejuvenation StudyDecember 3rd, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: